Clinical Trial Update: Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the safety, tolerability, and pharmacokinetics of BAT1006 in patients with advanced solid tumors has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BAT1006

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Advanced Solid Tumor | Phase 1 | Status: COMPLETED